Cell line anticancer drug. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy27

Cell Line, Tumor Cell Line Cell Line, Transformed Tumor Cells, Cultured Cells, Cultured HeLa Cells HT29 Cells HL-60 Cells K562 Cells HCT116 Cells MCF-7 Cells Fibroblasts Hep G2 Cells L Cells (Cell Line)Clone Cells Epithelial Cells Mitochondria KB Cells Jurkat Cells CHO Cells Cell Nucleus Caco-2 Cells Cell Membrane Spheroids, Cellular B-Lymphocytes Lymphocytes Neoplastic Stem Cells

Organisms7

Mice, Nude Mice, Inbred BALB C Cricetinae Mice, SCID Mice, Inbred C57BL Taxus Cricetulus

Diseases28

Neoplasms Breast Neoplasms Colonic Neoplasms Lung Neoplasms Cell Transformation, Neoplastic Melanoma Adenocarcinoma Neoplasms, Experimental Ovarian Neoplasms Leukemia P388 Neuroblastoma Prostatic Neoplasms Carcinoma, Hepatocellular Liver Neoplasms Carcinoma Pancreatic Neoplasms Leukemia Neoplasm Invasiveness Glioma Leukemia L1210 Neoplasm Metastasis Osteosarcoma Carcinoma, Squamous Cell Cell Transformation, Viral Glioblastoma Burkitt Lymphoma Brain Neoplasms Neovascularization, Pathologic

Chemicals and Drugs104

Antineoplastic Agents Doxorubicin Antineoplastic Agents, Phytogenic RNA, Messenger Antibiotics, Antineoplastic Cisplatin Drug Carriers P-Glycoprotein Neoplasm Proteins Ellipticines Enzyme Inhibitors Paclitaxel Camptothecin DNA Etoposide RNA, Small Interfering Caspases Tumor Suppressor Protein p53 Proto-Oncogene Proteins c-bcl-2 DNA Topoisomerases, Type II DNA, Neoplasm DNA-Binding Proteins Plant Extracts Prodrugs Caspase 3 Daunorubicin Topoisomerase I Inhibitors Antimetabolites, Antineoplastic Antibodies, Monoclonal Platinum Recombinant Proteins Mitomycin Multidrug Resistance-Associated Proteins Fluorouracil Transcription Factors RNA, Neoplasm Nanocapsules Proto-Oncogene Proteins Mitoxantrone ATP-Binding Cassette Transporters Organoplatinum Compounds DNA Primers Antigens, Neoplasm Nuclear Proteins Protein Kinase Inhibitors DNA Adducts Carrier Proteins Histone Deacetylase Inhibitors Xanthones Membrane Glycoproteins Antineoplastic Agents, Alkylating Tubulin Modulators Topoisomerase II Inhibitors Intercalating Agents Protein-Serine-Threonine Kinases Reactive Oxygen Species Hydroxamic Acids Topoisomerase Inhibitors Drugs, Investigational Anticarcinogenic Agents Membrane Proteins Thiazoles DNA, Complementary Indoles DNA Topoisomerases, Type I Pyrazines Tetrazolium Salts Piperazines Proto-Oncogene Proteins c-akt Coordination Complexes Vinblastine Benzoquinones Pyrimidines Boronic Acids bcl-2-Associated X Protein Recombinant Fusion Proteins Receptor, Epidermal Growth Factor Tumor Suppressor Proteins Liposomes Adjuvants, Pharmaceutic Apoptosis Regulatory Proteins NF-kappa B Depsipeptides Isoenzymes Radiation-Sensitizing Agents Sulfonamides Teniposide Poly(ADP-ribose) Polymerases Triterpenes Cyclin-Dependent Kinase Inhibitor p21 Caspase 9 Tumor Markers, Biological Razoxane Peptides Cell Cycle Proteins Glutathione Proteins Luciferases Oligopeptides Antigens, CD95 Bleomycin Proteasome Inhibitors Rhodamine 123 Triazines

Analytical, Diagnostic and Therapeutic Techniques and Equipment35

Drug Screening Assays, Antitumor Transfection Xenograft Model Antitumor Assays Drug Delivery Systems Inhibitory Concentration 50 Blotting, Western Drug Carriers Neoplasm Transplantation Flow Cytometry Reverse Transcriptase Polymerase Chain Reaction Transplantation, Heterologous Drug Design Drug Evaluation, Preclinical Neoplasms, Experimental Gene Expression Profiling Tumor Stem Cell Assay Drug Discovery Nanocapsules Immunohistochemistry Molecular Targeted Therapy Models, Biological Polymerase Chain Reaction Immunoblotting Cloning, Molecular Oligonucleotide Array Sequence Analysis Fluorescent Antibody Technique Blotting, Northern Gene Knockdown Techniques Cell Culture Techniques Karyotyping Antineoplastic Combined Chemotherapy Protocols Tumor Burden Phytotherapy Models, Molecular Clinical Trials, Phase I as Topic

Phenomena and Processes54

Apoptosis Drug Resistance, Neoplasm Cell Survival Cell Proliferation Gene Expression Regulation, Neoplastic Transfection Base Sequence Dose-Response Relationship, Drug Inhibitory Concentration 50 Cell Division Drug Synergism Drug Resistance, Multiple Signal Transduction Cell Cycle Drug Resistance Molecular Structure Gene Expression Down-Regulation DNA Damage Mutation Promoter Regions, Genetic Transcription, Genetic Phosphorylation Time Factors Amino Acid Sequence Cell Death Kinetics Gene Expression Regulation Cell Differentiation Up-Regulation Enzyme Activation Structure-Activity Relationship Phenotype RNA Interference Protein Binding Genetic Vectors Cell Growth Processes Genes, MDR DNA Adducts Cell Cycle Checkpoints DNA Repair Gene Silencing Cell Movement Binding Sites Biological Transport Plasmids G2 Phase Particle Size Cell Transformation, Viral Genes, p53 DNA Methylation Genes, Reporter Drug Interactions Gene Expression Regulation, Enzymologic

Disciplines and Occupations4

Drug Design Nanomedicine Drug Discovery Immunohistochemistry

Technology, Industry, Agriculture4

Nanoparticles Nanomedicine Nanocapsules Liposomes

Information Science3

Molecular Sequence Data Base Sequence Amino Acid Sequence

Health Care1

Clinical Trials, Phase I as Topic

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science

Cell Line, Tumor Cell Line Antineoplastic Agents Cell Line, Transformed Drug Screening Assays, Antitumor Tumor Cells, Cultured Apoptosis Neoplasms Drug Resistance, Neoplasm Cell Survival Doxorubicin Cell Proliferation Antineoplastic Agents, Phytogenic Mice, Nude RNA, Messenger Gene Expression Regulation, Neoplastic Antibiotics, Antineoplastic Transfection Cisplatin Xenograft Model Antitumor Assays Molecular Sequence Data Base Sequence Drug Delivery Systems Dose-Response Relationship, Drug Inhibitory Concentration 50 Cell Division Blotting, Western Drug Carriers Drug Synergism P-Glycoprotein Drug Resistance, Multiple Signal Transduction Neoplasm Proteins Breast Neoplasms Cell Cycle Colonic Neoplasms Neoplasm Transplantation Ellipticines Drug Resistance Flow Cytometry Reverse Transcriptase Polymerase Chain Reaction Enzyme Inhibitors Paclitaxel Camptothecin Molecular Structure Lung Neoplasms Gene Expression DNA Etoposide Down-Regulation DNA Damage Transplantation, Heterologous RNA, Small Interfering Caspases Mutation Cells, Cultured Drug Design Tumor Suppressor Protein p53 Proto-Oncogene Proteins c-bcl-2 HeLa Cells HT29 Cells Promoter Regions, Genetic DNA Topoisomerases, Type II DNA, Neoplasm DNA-Binding Proteins Plant Extracts HL-60 Cells Mice, Inbred BALB C Transcription, Genetic Phosphorylation Drug Evaluation, Preclinical Prodrugs Caspase 3 Cricetinae Daunorubicin Time Factors Amino Acid Sequence Topoisomerase I Inhibitors Cell Transformation, Neoplastic Melanoma Antimetabolites, Antineoplastic Cell Death Adenocarcinoma Kinetics Neoplasms, Experimental Gene Expression Regulation K562 Cells Antibodies, Monoclonal Cell Differentiation HCT116 Cells Ovarian Neoplasms Up-Regulation Nanoparticles Platinum Enzyme Activation Mice, SCID MCF-7 Cells Gene Expression Profiling Structure-Activity Relationship Tumor Stem Cell Assay

No FAQ available that match "cell line anticancer drug"